- Home
- Discussion Questions
- Lesson Plan
- Additional Lesson Ideas
- Additional Resources
- Printable .pdf of Entire Guide
(Adobe Acrobat required)
Additional Lesson Ideas
The lesson plan Great Debates "investigates the battle being waged between major pharmaceutical companies and American consumers fed up with paying the highest drug prices in the world." It explores the following questions:
- Will controlling the prices of prescription drugs hinder innovation?
- How can states control pharmaceutical prices so that all citizens have fair access?
- How do advertising and marketing influence the kinds of drugs doctors prescribe?
National Congress of State Legislators: Whose Special Interests?
These lesson plans have been developed to help students:
- Define key terms involved in the lobbying process and interest group politics
- Consider concerns that many citizens have with lobbyists and special interest groups
- Explore arguments in favor of interest group politics
- Discuss the impact of interest groups' activities on congressional legislation
HighWired.com: AIDS -- 20 Years Later
This series of lesson plans looks at people living with AIDS and the impact that it has on their communities. Since AIDS is often associated with drug addition, this site can extend the lesson through the following objectives:
- Examining the demographic profile for people with HIV/AIDS
- Providing information of communities' knowledge of HIV/AIDS
- Compiling information on the global impact of HIV/AIDS
Web-exclusive video about the connection between Meth abuse and HIV/AIDS transmission in the gay community can be found at www.pbs.org/frontline/meth/body.
On May 30 and 31, 2006, FRONTLINE presents the definitive chronicle of one of the worst pandemics the world has ever known in The Age of AIDS. For more information on this program, visit http://www.pbs.org/frontline/aids/.
FRONTLINE: Regulating Drugs and the Creation of the FDA
This two-step lesson plan traces the development of the Food and Drug Administration (FDA), examines the jurisdiction of the FDA, and looks at the issues facing the FDA today.